fbpx

Paul Little

Paul Little

Paul Little

Operating Partner

Paul Little joined Lundbeckfonden Emerge in 2016 as an associate. Paul’s focus is on scientific evaluation and commercial assessment of early investment opportunities. He is CEO of Insusense Therapeutics and Board representative in Folium.

Direct +45 3912 8083
pl@lundbeckfonden.com